Piramal Pharma Limited — Updates, 14-02-2026: General Updates
14-02-2026 | 12:57 pm
14-02-2026 | 12:57 pm
Piramal Pharma's Digwal facility received 4 FDA observations related to procedure enhancements, not data integrity. The company is preparing a response for these 'Voluntary Action Indicated' observations.
No comments yet. Be the first to comment!
